• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿神经母细胞瘤的治疗。

Management of Neuroblastoma in Pediatric Patients.

机构信息

Department of Surgery, Pediatric Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

Department of Surgery, Baylor College of Medicine, 6701 Fannin Street, Houston, TX 77030, USA.

出版信息

Surg Oncol Clin N Am. 2021 Apr;30(2):291-304. doi: 10.1016/j.soc.2020.11.010. Epub 2021 Feb 10.

DOI:10.1016/j.soc.2020.11.010
PMID:33706901
Abstract

Surgeons caring for patients with neuroblastoma must be familiar with recent developments in assessing risk. In particular, the Children's Oncology Group, along with major international groups, uses the International Neuroblastoma Risk Group Staging System as a risk assessment tool. Accurate risk determination is essential for optimal surgical therapy. Some tumors like neonatal adrenal neuroblastomas and those in the metastatic category can be observed. Very-low-risk and low-risk neuroblastomas can be treated with surgery alone. Intermediate-risk tumors also often require systemic chemotherapy.

摘要

外科医生在照顾神经母细胞瘤患者时,必须熟悉风险评估的最新进展。特别是,儿童肿瘤学组与主要的国际组织一起,将国际神经母细胞瘤风险组分期系统用作风险评估工具。准确的风险确定对于最佳手术治疗至关重要。一些肿瘤,如新生儿肾上腺神经母细胞瘤和转移性肿瘤,可以进行观察。极低风险和低风险的神经母细胞瘤可以单独通过手术治疗。中危肿瘤通常也需要全身化疗。

相似文献

1
Management of Neuroblastoma in Pediatric Patients.小儿神经母细胞瘤的治疗。
Surg Oncol Clin N Am. 2021 Apr;30(2):291-304. doi: 10.1016/j.soc.2020.11.010. Epub 2021 Feb 10.
2
Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China.中国单中心研究:单纯手术治疗低危神经母细胞瘤的长期预后
World J Pediatr. 2019 Apr;15(2):148-152. doi: 10.1007/s12519-018-0205-z. Epub 2018 Nov 16.
3
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.一项针对小婴儿神经母细胞瘤期待观察作为一线治疗的前瞻性研究:一项儿童肿瘤协作组研究。
Ann Surg. 2012 Oct;256(4):573-80. doi: 10.1097/SLA.0b013e31826cbbbd.
4
Clinical outcomes in children with adrenal neuroblastoma undergoing open versus laparoscopic adrenalectomy.儿童肾上腺神经母细胞瘤行开放与腹腔镜肾上腺切除术的临床结局比较。
J Pediatr Surg. 2013 Aug;48(8):1727-32. doi: 10.1016/j.jpedsurg.2013.03.056.
5
Bilateral adrenal neuroblastoma in the infant: Is it an image-defined risk factor?婴儿双侧肾上腺神经母细胞瘤:它是一种影像定义的风险因素吗?
Pediatr Hematol Oncol. 2016 May;33(4):259-63. doi: 10.3109/08880018.2016.1160169.
6
Surgical management in pediatric neuroblastoma diagnosis and treatment: a 20-year, single-center experience.小儿神经母细胞瘤的外科治疗诊断和治疗:20 年单中心经验。
World J Pediatr. 2022 Feb;18(2):120-125. doi: 10.1007/s12519-021-00490-5. Epub 2021 Dec 2.
7
The impact of gross total resection on local control and survival in high-risk neuroblastoma.根治性全切除对高危神经母细胞瘤局部控制和生存的影响。
J Pediatr Surg. 2004 Mar;39(3):412-7; discussion 412-7. doi: 10.1016/j.jpedsurg.2003.11.028.
8
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.低风险神经母细胞瘤患者单纯手术或限制化疗的治疗效果:儿童肿瘤协作组研究 P9641 的结果。
J Clin Oncol. 2012 May 20;30(15):1842-8. doi: 10.1200/JCO.2011.37.9990. Epub 2012 Apr 23.
9
The impact of gross total resection on survival in children with stage III/IV neuroblastoma--study of clinical efficacy in 21 cases.全切除对Ⅲ/Ⅳ期神经母细胞瘤患儿生存的影响——21例临床疗效研究
Eur Rev Med Pharmacol Sci. 2014 Aug;18(16):2253-7.
10
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.A期神经母细胞瘤的自然病史与生物学特性:一项儿科肿瘤学组的研究
J Pediatr Hematol Oncol. 2000 May-Jun;22(3):197-205. doi: 10.1097/00043426-200005000-00003.

引用本文的文献

1
Idebenone: Clinical Potential Beyond Neurological Diseases.艾地苯醌:超越神经疾病的临床潜力。
Drug Des Devel Ther. 2025 Sep 9;19:7929-7946. doi: 10.2147/DDDT.S515053. eCollection 2025.
2
Placental mesenchymal stem cell-derived interleukin-6 promotes neuroblastoma progression.胎盘间充质干细胞衍生的白细胞介素-6促进神经母细胞瘤进展。
Am J Cancer Res. 2025 Aug 25;15(8):3712-3727. doi: 10.62347/KNYX4079. eCollection 2025.
3
Correlation of senescence-related gene FEN1 on neuroblastoma progression and cisplatin chemotherapy sensitivity.
衰老相关基因FEN1与神经母细胞瘤进展及顺铂化疗敏感性的相关性
Oncol Res. 2025 Jun 26;33(7):1695-1708. doi: 10.32604/or.2025.060021. eCollection 2025.
4
Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma.蛋白质组学分析揭示染色质重塑是神经母细胞瘤的一个潜在治疗靶点。
J Transl Med. 2025 Feb 26;23(1):234. doi: 10.1186/s12967-025-06298-5.
5
Stratification of Anatomical Imaging Features Between High-Risk and Non-High-Risk Groups in Neuroblastoma.神经母细胞瘤高危组与非高危组解剖学影像特征的分层
Cancer Control. 2025 Jan-Dec;32:10732748251315883. doi: 10.1177/10732748251315883.
6
Sonopermeation With Size-sorted Microbubbles Synergistically Increases Survival and Enhances Tumor Apoptosis With L-DOX by Increasing Vascular Permeability and Perfusion in Neuroblastoma Xenografts.使用大小分选微泡的超声透入通过增加神经母细胞瘤异种移植瘤的血管通透性和灌注,协同提高存活率并增强L-DOX诱导的肿瘤细胞凋亡。
Ultrasound Med Biol. 2025 Feb;51(2):348-357. doi: 10.1016/j.ultrasmedbio.2024.10.014. Epub 2024 Nov 23.
7
Exploring the role of neutrophil extracellular traps in neuroblastoma: identification of molecular subtypes and prognostic implications.探索中性粒细胞胞外诱捕网在神经母细胞瘤中的作用:分子亚型的鉴定及预后意义
Front Oncol. 2024 Nov 7;14:1361871. doi: 10.3389/fonc.2024.1361871. eCollection 2024.
8
EIF2S1 Silencing Impedes Neuroblastoma Development Through GPX4 Inactivation and Ferroptosis Induction.EIF2S1基因沉默通过使GPX4失活和诱导铁死亡来阻碍神经母细胞瘤的发展。
Int J Genomics. 2024 Oct 19;2024:6594426. doi: 10.1155/2024/6594426. eCollection 2024.
9
Use of Radioguided Surgery for Small and Difficult-to-Locate Relapsed MIBG (+) High-Risk Neuroblastoma Lesions.放射性引导手术在小的且难以定位的复发性MIBG(+)高危神经母细胞瘤病灶中的应用。
Cancers (Basel). 2024 Sep 30;16(19):3348. doi: 10.3390/cancers16193348.
10
Neuroblastoma-A Review of Combination Immunotherapy.神经母细胞瘤的联合免疫治疗综述。
Int J Mol Sci. 2024 Jul 15;25(14):7730. doi: 10.3390/ijms25147730.